Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Undecimal Bio launches with $18M to take siRNA beyond liver disease

After spinning out one half of its business this summer, Eleven Therapeutics is carving out the other half with $18 million to join companies like Arrowhead and Alnylam that ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 12 October →